NCT05982652

Brief Summary

In this study, the SCI patients were sub-grouped on the basis of symptoms into symptomatic and asymptomatic groups and measured HRV during resting and tilt up tests to compare their cardiovascular autonomic functions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 13, 2022

Completed
10 months until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 9, 2023

Status Verified

August 1, 2023

Enrollment Period

1.7 years

First QC Date

October 13, 2022

Last Update Submit

August 7, 2023

Conditions

Keywords

Spinal Cord InjuriesOrthostatic HypotensionHeart rate variabilityAutonomic nervous system

Outcome Measures

Primary Outcomes (2)

  • Differences of heart rate variability between groups (OH vs non-OH, asymptomatic-OH vs symptomatic-OH group)

    mean HR (heart rate), mean RR(RR interval), RMSSD (mean square of the successive R-R interval differences), SDNN (standard deviation of normal-to-normal interval), LF (low frequency) domain, HF(High frequency) domain

    at the test time (15minutes)

  • Logistic regression analysis of heart rate variability variables according to OH and presence of symptom

    the investigators conducted logistic regression analysis to evaluate the significance and impact of HRV variables associated with orthostatic hypotension and its symptoms in spinal cord injury patients.

    at the test time (15minutes)

Study Arms (3)

non-OH group

without orthostaric hypotension in spinal cord injuries

symptomatic OH group

Symptomatic individuals in a patient population diagnosed with orthostatic hypotension (Symptom : dizziness, visual disturbance, nausea and headache)

asymptomatic OH group

Asymptomatic individuals in a patient population diagnosed with orthostatic hypotension

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals with SCI were recruited from a single university-affiliated rehabilitation hospital.

You may qualify if:

  • spinal cord injury with or without OH
  • aged 19 or older
  • ASIA Impairment Scale (AIS) A to D
  • neurological level of injury above T6.

You may not qualify if:

  • Those with heart and respiratory diseases, neurological diseases other than SCI - medically unstable states
  • Those who are taking medications affecting BP that cannot be stopped

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pusan National University Yangsan Hospital, Geumo-ro 20, Mulgeum-eup

Yangsan, Gyeongsangnam-do, 50612, South Korea

Location

Related Publications (1)

  • Stampas A, Zhu L, Li S. Heart rate variability in spinal cord injury: Asymptomatic orthostatic hypotension is a confounding variable. Neurosci Lett. 2019 Jun 11;703:213-218. doi: 10.1016/j.neulet.2019.03.020. Epub 2019 Mar 20.

    PMID: 30904574BACKGROUND

MeSH Terms

Conditions

Spinal Cord InjuriesHypotension, Orthostatic

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesOrthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesHypotensionVascular DiseasesCardiovascular Diseases

Study Officials

  • PARK HAERI, Master

    Pusan National University Yangsan Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

October 13, 2022

First Posted

August 8, 2023

Study Start

January 1, 2022

Primary Completion

August 31, 2023

Study Completion

December 31, 2023

Last Updated

August 9, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations